MarketsandMarkets Virtual Conference on Liquid Biopsy ( Time Zone - CENTRAL EUROPEAN TIME (CET)

20 -21 May 2020
CONFERENCE SPEAKERS
Speakers
Karl J. DSilva
Karl J. DSilva
Medical Director, Clinical Asst. Professor of Medicine,
Tufts University School of Medicine, Lahey Hospitals and Medical Center



Dana E. Connors
Dana E. Connors
Senior Scientific Project Manager,
Cancer Foundation for the National Institutes of Health



Dr Emmanouil Karteris
Dr Emmanouil Karteris
Head,
CBCEL, London



Antony Newton
Antony Newton
VP Business Development,
Inivata



DR CATHERINE ALIXPANABIÈRES PhD-
DR CATHERINE ALIXPANABIÈRES PhD-
Director of the Laboratory Rare Circulating Human Cells (LCCRH),
l’Université et CHU de Montpellier, France, Europe



Jennifer Whittington
Jennifer Whittington
Surgical Oncologist,
Queens Hospital Cancer Center



Dr. Harsha Doddihal
Dr. Harsha Doddihal
Clinical researcher, Oncologist,
Fortis Hospital



YOUHE GAO
YOUHE GAO
Professor Department of Biochemistry and Molecular Biology, ,
Beijing Normal University



IMEN EL AMOURI
IMEN EL AMOURI
Team Lead Liquid Biopsy Biobank,
Indivumed



Kevin Wang
Kevin Wang
Director, Program for Neuroproteomics and Biomarkers Research,
University of Florida


Dr. Kevin Wang is the Director of the Program for NNBR and Associate Professor of Emergency Medicine at the University of Florida in USA.  Dr. Wang is a neurotrauma researcher since the late 1990’s. He has served as President and Council Member of the National Neurotrauma society, Board Member, Board of Governors of the International Brain Injury Association and Presidium Member of the Academy for Multidisciplinary Neurotraumatology. He is a co-founder of a biotechnology company Gryphon Bio, Inc. His research focus is translational research for biomarkers and therapies for traumatic brain injury (TBI), spinal cord injury, post-traumatic epilepsy, and chronic traumatic encephalopathy.  Two acute TBI blood-based protein biomarkers (UCH-L1/GFAP) he co-discovered have received FDA clearance as the first in vitro diagnostic tests for detecting pathoanatomical lesions in TBI patients. He also holds leadership positions on various TBI initiative such as International TBI Research Initiative (InTBIR), and multicenter TBI consortium studies (e.g. TRACK-TBI, CENTER-TBI, ICON-TBI).


JIANYU RAO, M.D
JIANYU RAO, M.D
Vice Chair- Diagnostic Technology Innovation, Director-Cytopathology, Director-International Telepathology Dept. Pathology and Lab Med, UCLA,
David Geffen School of Medicine